F Nelli - AI Profile | 人才画像

基本信息

浏览量：10

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer

L Trodella,F De Marinis,R M D'Angelillo,S Ramella,A Cesario,S Valente,F Nelli,M R Migliorino,S Margaritora,G M Corbo,V Porziella,M Ciresa,

Lung Cancer（2006）

引用13浏览0WOS引用

Epidemiology of nephrolithiasis today

M Amato, M L Lusini,F Nelli

UROLOGIA INTERNATIONALIS（2004）

引用49浏览0WOS引用

817 Optimized schedule of gemcitabine (G), paclitaxel (T) and cisplatin (P) in the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC): results of a phase II study

F NELLI,F DEMARINIS,G DAURIA,A DEPASQUALECERATTI, M MIGLIORRINO,G METRO, M DIMOLFETTA, M EVANGELISTA, E CORTESI

Ejc Supplements（2003）

引用0浏览0引用

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

F DEMARINIS,C GRIDELLI, M LOMBARDO,L PAOLUZZI,F FERRAU,S BARBERA,O BERTETTO,S BERNI,R LABIANCA,F NELLI

Lung Cancer（2003）

引用0浏览0引用

P-236 Induction chemotherapy (CT) with gemcitabine (G), paclitaxel (T), and cisplatin (P) and subsequent radiotherapy (TRT) with concomitant G for stage IIIB non-small cell lung cancer (NSCLC): results of a multicenter phase II study

E CORTESI,L TRODELLA,F NELLI,R DANGELILLO,G DAURIA, S RAMELLA, C DIFONZO,A DEPASQUALECERATTI

Lung Cancer（2003）

引用1浏览0引用

P-237 Combination of gemcitabine-paclitaxel-cisplatin (GTP) as induction chemotherapy for unresectable stage IIIA(N2) non-small cell lung cancer (NSCLC): results of a multicenter phase II study

F NELLI,F DEMARINIS,M MIGLIORINO,O MARTELLI,S TREGGIARI,C CRISPINO, L BRANCACCIO,L PORTALONE,L PAOLUZZI, E CORTESI

Lung Cancer（2003）

引用0浏览0引用

Phase Ii Study Of Vinorelbine (V) And Docetaxel (D) As Second Line Therapy For Advanced Non-Small Cell Lung Cancer (Nsclc) Patients Resistant To Paclitaxel Or Gemcitabine-Platinum Based Regimens

R Saltarelli,F Nelli,G Naso,L Moscetti,A Mancuso, C Di Fonzo, G D'Auria, Ad Ceratti,L Paoluzzi,E Cortesi

INTERNATIONAL JOURNAL OF CANCERpp.438-439, (2002)

引用0浏览0引用

A Phase Ii Trial Of Gemcitabine-Cisplatin-Paclitaxel (Gdt) Chemotherapy As Neoadjuvant Treatment Of Unresectable Stage Iiia(N2)-Iiib Non-Small Cell Lung Cancer (Nsclc): Preliminary Results

F De Marinis,F Cappuzzo,F Nelli, G Benedetti,Mr Migliorino,E Cortesi,L Portalone,O Martelli,S Bartolini,L Crino

INTERNATIONAL JOURNAL OF CANCERpp.413-413, (2002)

引用0浏览0引用

A three-week schedule of gemcitabine plus cisplatin as induction chemotherapy for stage III non-small cell lung cancer (NSCLC): final results of a monoinstitutional phase II study

M.R. Migliorino,F. Nelli,F. Facciolo,A. Cipri,R. Belli,M.V. Ammaturo,O. Ariganello,L. Paoluzzi,M. Di Molfetta,F. De Marinis

European Journal of Cancer (2001)

引用0浏览0EI引用

Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB non-small cell lung cancer (NSCLC). A mono-institutional phase II study with a 21 days schedule

MR Migliorino,F De Marinis,F Nelli, F Faccialo, MV Ammaturo,S Ramponi, O Ariganello,M Di Molfetta, F Diana,R Belli,M Martelli

ANNALS OF ONCOLOGYno. SUPnan (2000): 8-8

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn